119 results

• Study Finds Ketoacidosis Risks from Side Effects of Invokana, Jardiance, Similar Diabetes Drugs

  May 12, 2025

  Irvin Jackson

  Diabetes drugs like Invokana may reduce the risk of kidney injury and death after surgery, but may also increase the risk of a form of diabetic ketoacidosis that is hard to detect.

• Diabetes Smartphone Alerts May Be Impacted by Hardware, Software Updates: FDA Warns

  February 7, 2025

  Martha Garcia

  The FDA is warning that smartphone updates may accidentally disable apps being used to monitor diabetes patients, resulting in severe injuries or death.

• Medtronic MiniMed Insulin Pump Recall Over Battery Failure Risks

  October 7, 2024

  Irvin Jackson

  FDA has announced a class I recall impacting tens of thousands of Medtronic MiniMed insulin pumps, due to risks that the battery may deplete rapidly after the device has been dropped or physically impacted.

• Study Finds Jardiance Does Not Significantly Reduce Heart Failure or Mortality Rates Among Patients

  May 13, 2024

  Grace Muller

  A new study finds the heart benefits of Jardiance are minimal at best, despite years of advertising by the manufacturers claiming superior cardiovascular benefits for diabetes patients.

• Case Study Links Tepezza Side Effects to a Potential Risks for Diabetics

  October 4, 2023

  Irvin Jackson

  Tepezza side effects may cause a loss of glycemic control and increased risk of diabetic ketoacidosis, according to the findings of a new study.

• Lipitor, Zocor, Similar Cholesterol Drugs May Increase Risk of Diabetes Progression, Hyperglycemia: Study

  October 8, 2021

  Irvin Jackson

  The findings of a new study indicate taking cholesterol drugs like Lipitor and Zocor could speed up the progression of diabetes, increasing the risk of adverse health complications.

• Diabetic Ketoacidosis Risk Tripled Among Users of Invokana, Similar Diabetes Drugs: Study

  August 5, 2020

  Irvin Jackson

  A new study appears to confirm FDA warnings that Invokana and similar diabetes drugs increase the risk of diabetic ketoacidosis in type 2 diabetes patients.

• Invokana, Farxiga and Similar Drugs Need Stronger Ketoacidosis Warnings for Type 1 Diabetics: Public Citizen

  July 7, 2020

  Irvin Jackson

  Public Citizen has petitioned the FDA to add black box warnings to Invokana and similar drugs, contraindicating their use by Type 1 diabetics due to the risk of diabetic ketoacidosis.

• Flesh-Eating Fournier Gangrene Infections Linked to Invokana, Farxiga, Other SGLT2 Drugs: FDA Study

  May 14, 2019

  Irvin Jackson

  A new study by FDA researchers appears to verify links between Invokana and similar diabetes drugs and a life-threatening infection that attacks the genitals.

• Invokana Lawsuit Filed Over Right Leg Amputation

  January 3, 2019

  Irvin Jackson

  A new Invokana lawsuit indicates that the side effects of the diabetes drug caused a Louisiana woman to have her right leg amputated above the knee.